REDUCE MRSA Trial Lead Author Discusses Landmark Paper in CDC's Healthcare Blog
Today, on CDC's Safe Healthcare blog, lead author of the REDUCE MRSA trial, Dr. Susan Huang, discusses the results of the landmark study and provides insight into what the findings mean for infection prevention and patient safety.
The REDUCE MRSA trial found that using germ-killing soap and ointment on all intensive-care unit (ICU) patients could reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs.
Huang is an associate professor at the University of California Irvine School of Medicine and medical director of epidemiology and infection prevention at UC Irvine Health.
Join the conversation by clicking HERE.
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
